Location History:
- Sodertalje, SE (2010)
- Södertälje, SE (2009 - 2012)
Company Filing History:
4 out of 1,500 
1 out of 123 
Years Active: 2009-2012
Title: Didier Rotticci: Innovator in Pharmaceutical Patents
Introduction
Didier Rotticci is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases related to Aβ (beta-amyloid) pathologies. With a total of 4 patents to his name, Rotticci's work has the potential to impact the lives of many individuals suffering from cognitive impairments and related disorders.
Latest Patents
Rotticci's latest patents include innovative compounds aimed at addressing Aβ-related pathologies. One of his notable inventions is the "Dihydropyridopyrimidines for the treatment of AB-related pathologies," which involves dihydropyridopyrimidine compounds and their therapeutically acceptable salts. This invention outlines processes for making these compounds and methods for their use in treating Aβ-related conditions. Another significant patent is for "Substituted isoindoles for the treatment and/or prevention of Aβ-related pathologies." This invention focuses on novel compounds and their pharmaceutical compositions, targeting various disorders associated with cognitive impairment, including Alzheimer's disease and other forms of dementia.
Career Highlights
Throughout his career, Didier Rotticci has worked with prominent companies in the pharmaceutical industry. He has been associated with AstraZeneca AB and Astex Therapeutics Limited, where he has contributed to research and development efforts aimed at creating effective treatments for complex diseases.
Collaborations
Rotticci has collaborated with several professionals in his field, including Jörg Holenz and Laszlo Rakos. These collaborations have likely enhanced the scope and impact of his research, leading to innovative solutions in the pharmaceutical sector.
Conclusion
Didier Rotticci stands out as a significant figure in the realm of pharmaceutical inventions, with a focus on addressing critical health issues related to cognitive impairments. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.